Document is current
Any future updates will be listed below
-
Authors
Vriend, Esther M. C.
Galenkamp, Henrike
Herrema, Hilde
Nieuwdorp, Max
van den Born, Bert-Jan H.
Verhaar, Barbara J. H.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (189235)
ZonMw (09150182010020)
European Research Council (101141346)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 3 December 2024
First Online: 19 December 2024
Competing interests
: M.N. is co-founder and member of the Scientific Advisory Board of Caelus Pharmaceuticals and Advanced Microbial Interventions, the Netherlands. None of these are directly relevant to the current paper. None of the other authors declared competing interests.
